[吸入的乐伏多巴:从证据到经验]
J C Martínez-Castrillo1, I Pareés-Moreno2, J L López Sendón-Moreno2
1Hospital Universitario Ramón y Cajal, 28034 Madrid, España.
Revista de neurologia
|June 25, 2024
概括
帕金森病患者经常面临运动波动. 按需的治疗方法,如皮下阿波莫尔芬,吸入利沃多巴和舌下阿波莫尔芬,可以更快地缓解患者的痛苦.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 经常导致运动波动 ("关闭"周期),显著影响日常生活和生活质量.
- 患者经常经历这些波动,尽管优化了口服药物治疗方案.
研究的目的:
- 审查对帕金森病运动波动的按需治疗方法.
- 为了比较可用的按需治疗的药理动力学概况,作用开始,持续时间和副作用概况.
- 突出吸入式勒沃多巴作为一种较新的剂量形式的作用和经验.
主要方法:
- 对帕金森病运动波动的当前按需治疗方法的审查.
- 皮下阿波莫尔芬,吸入的莱沃多巴和舌下阿波莫尔芬的比较分析.
- 专注于吸入利沃多巴的临床经验.
主要成果:
- 皮下阿波莫尔芬提供了最快的起作用.
- 舌下阿波莫尔芬提供了最长的临床效果持续时间.
- 吸入的乐伏多巴具有有利的副作用概况.
结论:
- 按需治疗对于管理帕金森病的运动波动至关重要.
- 每种疗法 (皮下阿波莫尔芬,吸入的勒沃多巴,舌下阿波莫尔芬) 都具有不同的特点.
- 患者特定的需求和情况指导选择最合适的按需治疗.
相关概念视频
01:24Parkinson's Disease: Treatment
255
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
255
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K